Search all trials

Find therapies in clinical trials near you – page 58

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Cholangiocarcinoma

Not recruiting

Registered drugNo placebo

Study of Durvalumab and Tremelimumab with Y-90 SIRT Therapy for Patients with Advanced Intrahepatic Biliary Tract Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drug

Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Azathioprine

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Hormone receptor positive breast cancer+1

Not recruiting

Registered drugNo placebo

Study of Giredestrant, Triptorelin, and Anastrozole in Premenopausal Women with ER-Positive/HER2-Negative Early Breast Cancer

Registered drugNo placebo

Germany

Participants:18–64 years
Substances:Anastrozole

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Investigational

Study on Nalbuphine ER for Treating Cough in Patients with Idiopathic Pulmonary Fibrosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Nalbuphine Hydrochloride

Contact Research Centre

Pyoderma gangrenosum

Not recruiting

Registered drug

Study on Vilobelimab and Drug Combination for Treating Ulcerative Pyoderma Gangrenosum in Adults

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Betamethasone

Contact Research Centre

Asthma+1

Not recruiting

Registered drug

Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze

Registered drug

Germany

Participants:0–17 years
Substances:Budesonide

Contact Research Centre

Breast cancer+3

Not recruiting

Registered drugNo placebo

Study on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drug

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drug

Study on Venetoclax and Azacitidine for Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Migraine+2

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atogepant

Contact Research Centre

Study of Tislelizumab, Dacarbazine, Vinblastine Sulfate, and Doxorubicin Hydrochloride for Adults with Early-Stage Unfavorable Hodgkin Lymphoma

Not recruiting

Registered drugNo placebo

Study of Tislelizumab, Dacarbazine, Vinblastine Sulfate, and Doxorubicin Hydrochloride for Adults with Early-Stage Unfavorable Hodgkin Lymphoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Dacarbazine

Contact Research Centre

Find therapies in clinical trials near you – page 58

755 trials match your criteria

Cholangiocarcinoma

Study of Durvalumab and Tremelimumab with Y-90 SIRT Therapy for Patients with Advanced Intrahepatic Biliary Tract Cancer

Colitis ulcerative

Study on the Effectiveness and Safety of JNJ-77242113 for Patients with Moderate to Severe Ulcerative Colitis

Non-small cell lung cancer

Study of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments

Hormone receptor positive breast cancer+1

Study of Giredestrant, Triptorelin, and Anastrozole in Premenopausal Women with ER-Positive/HER2-Negative Early Breast Cancer

Idiopathic pulmonary fibrosis

Study on Nalbuphine ER for Treating Cough in Patients with Idiopathic Pulmonary Fibrosis

Pyoderma gangrenosum

Study on Vilobelimab and Drug Combination for Treating Ulcerative Pyoderma Gangrenosum in Adults

Asthma+1

Study on the Effects and Safety of Dupilumab for Children Aged 2 to Under 6 with Uncontrolled Asthma or Severe Asthmatic Wheeze

Breast cancer+3

Study on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk

Neoplasm malignant

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Myelodysplastic syndrome

Study on Venetoclax and Azacitidine for Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome

Migraine+2

Study on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine

Study of Tislelizumab, Dacarbazine, Vinblastine Sulfate, and Doxorubicin Hydrochloride for Adults with Early-Stage Unfavorable Hodgkin Lymphoma

Study of Tislelizumab, Dacarbazine, Vinblastine Sulfate, and Doxorubicin Hydrochloride for Adults with Early-Stage Unfavorable Hodgkin Lymphoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.